Product logins

Find logins to all Clarivate products below.


Dee Chaudhary

Director, Consulting

With more than 25 years in life sciences and a passion for patients, Dee Chaudhary is a Director with Clarivate’s Commercial Strategy Consulting practice.  Her work in consulting, and within the biopharmaceutical industry has primarily focused on HUB/patient services, launch readiness, CMS policy impact, customer experience and market access strategy in the hematology and oncology space.

Dee has extensive professional experience with 340B pricing, reimbursement strategy, product positioning and value propositions for oral and infusible agents.  She has led HUB migrations, benchmarking engagements, customer satisfaction projects, omni-channel projects, product differentiation, pricing and positioning efforts, and payer landscape analysis.  Furthermore, Dee has an in-depth understanding of the hematology and oncology market landscape, targeted and cellular therapies, and has a strong interest and experience in other therapeutic areas including cardiology, neuroscience, med tech immunotherapy, and using technology to advance health and access. She has been invited to presented at Asembia, ISPOR and other clinical meetings, and has authored multiple trainings and white papers.

Prior to joining Clarivate, Dee held a variety roles at small and large biopharmaceutical organizations and consulting firms, including National Director of Market Access, Reimbursement and Trade, Senior Director of Customer Experience, and Assistant Director of Reimbursement Consulting. Dee holds a BA from Gustavus Adolphus College in History, and an MBA in Healthcare Administration.


arrow_forward
Get in touch with Dee

Latest news

News April 29, 2025
Clarivate Reports First Quarter 2025 Results

— Accelerated recurring organic revenue growth — — Reaffirmed 2025 Outlook — — Repurchased $50 million ordinary shares — London, UK — April 29, 2025 Clarivate Plc (NYSE: CLVT) (the…

News April 23, 2025
Clarivate Launches DRG Commercial Analytics 360 Enabling Medtech Companies to Advance Commercial Strategy and Execution

New solution provides integrated provider intelligence and real-world data to optimize targeting, strategic planning and patient access across commercial organizations London, U.K. April 23, 2025: Clarivate Plc (NYSE:CLVT), a leading…

News April 23, 2025
Clarivate Releases EndNote 2025 with AI-Powered Research Tools

Enhancing research efficiency and accuracy with newly integrated features

Related resources

Navigating uncertainty: What’s keeping healthcare execs up at night in this new era Navigating uncertainty: What’s keeping healthcare execs up at night in this new era
Blog April 2, 2025
Navigating uncertainty: What’s keeping healthcare execs up at night in this new era
Market Access Pharma Portfolio strategy Regulatory Research commercialization
Five Medtech Trends to Watch in 2025 Five Medtech Trends to Watch in 2025
Blog February 11, 2025
Five Medtech Trends to Watch in 2025
Medical technology Medtech Medtech Resource Center
The trends to watch in 2025 The trends to watch in 2025
Blog January 8, 2025
The trends to watch in 2025
This small biotech notched a big win for rare disease patients with a canny market access strategy This small biotech notched a big win for rare disease patients with a canny market access strategy
Blog December 19, 2024
This small biotech notched a big win for rare disease patients with a canny market access strategy
Market Access